|
|
 |
Publications |
|
|
|
Find here most important and recent CDL Pharma's publications.
| |
| Natural Polymorphism of NS3 Protease Domain Strains HCV-1 in HCV and HIV-HCV Co-infected Patients : Virological and Clinical Implication for Drug Resistant Viruses
Authors : P. Halfon, [...], G. Pénaranda, [...], H. Khiri
58th Annual Meeting of The American Association for the Study of Liver Diseases (November 2007)
| SVRScore : A Novel and Highly Predictive Score for SVR Prediction in Chronic Hepatitis C Genotype 1 Infected Patients
Authors : P. Halfon, G. Pénaranda, [...], D. Ouzan
58th Annual Meeting of the American Association for the Study of Liver Disease (November 2007)
| Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients
Authors : Y. Maor, [...], G. Pénaranda, [...], P. Halfon
Published in : Haemophilia (November 2007)
| Estimation de la fibrose du foie utilisant des marqueurs non-invasifs chez des patients co-infectés VIH-VHC : Etude Fibrovic 2 ANRS HCO2
Authors : P. Halfon, [...], G. Pénaranda, [...], P. Cacoub
61èmes journées de l'AFEF - Grenoble (September 2007)
| Détermination des stades de fibrose, reproductibilité et robutesse des tests sanguins de fibrose dans l'hépatite chronique C
Authors : P. Calès, [...], G. Pénaranda, [...], J. Boursier
61èmes journées de l'AFEF - Grenoble (September 2007)
| External Validation of FibroIndex
Authors : P. Halfon, [...], G. Pénaranda, [...], M. Boulière
Published in : Hepatology (July 2007)
| Intérêt et limites des méthodes non invasives de prédiction de la fibrose hépatique au cours de l'hépatite C : une alternative à la biopsie hépatique
Authors : P. Halfon, [...], G. Pénaranda, [...], P. Cacoub
Published in : La Presse Médicale (March 2007)
| Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C
Authors : P. Halfon, [...], G. Pénaranda, [...], V. Paradis
Published in : Journal of Hepatology (March 2007)
| Prospective Evaluation of the Hybrid Capture 2 and AMPLICOR Human Papillomavirus (HPV) Tests for Detection of 13 High-Risk HPV Genotypes in Atypical Squamous Cells of Uncertain Significance
Authors : P. Halfon, [...], G. Pénaranda, [...], B. Blanc
Published in : Journal of Clinical Microbiology (February 2007)
| |
| Non invasive fibrosis serum markers in chronic hepatitis C virus infection
Authors : P. Halfon, [...], G. Pénaranda, [...],P.Cacoub
Published in : Revue de médecine interne (October 2006)
| Validation and Comparison of Indexes for Fibrosis and Cirrhosis Prediction in Chronic Hepatitis C Patients : Proposal for a pragmatic approach classification without liver biopsies
Authors : M. Bourlière, G. Pénaranda, [...], R. Deydier, [...], P. Halfon
Published in : Journal of Viral Hepatitis (October 2006)
| Combinaison de Marqueurs Sanguins Non Invasifs (Fitrotest, Hepascore, APRI et Forns) pour la prédiction de Fibrose du Foie chez les Patients Infectés par le VHC
Authors : M. Bourlière, [...], G. Pénaranda, [...], P. Halfon
59ème Journées de l'AFEF (Association Française pour l'Etude du Foie), Paris (October 2006)
| Meta-analyse des scores sanguins de fibrose hépatique au cours des hépatites chroniques C
Authors : . Calès, [...], G. Pénaranda, [...], C. Trocme
59ème Journées de l'AFEF (Association Française pour l'Etude du Foie), Paris (October 2006)
| Hépatite aigüe autochtone : étude des sources de contamination et des voies de transmission de quatre nouveaux cas survenus en région PACA
Authors : C.Renou, [...], G. Pénaranda, [...], N.Pavio
59ème Journées de l'AFEF (Association Française pour l'Etude du Foie), Paris (October 2006)
| Performance diagnostique des tests sanguins de fibrose hépatique pour la fibrose sevère et la cirrhose
Authors :P.Calès, [...], G. Pénaranda, [...], F. Lunel
59ème Journées de l'AFEF (Association Française pour l'Etude du Foie), Paris (October 2006)
| Independent comparison of 4 blood scores of liver fibrosis in chronic hepatitis C : FibroMeter, Fibrotest, Hepascore, and APRI
Authors : P.Halfon, [...], G. Pénaranda, [...], V. Paradis
57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston (October 2006)
| Independent assesment and Cost-performance Analysis of Noninvasive Liver Fibrosis Biomarkers in HIV-HCV Coinfected Patients : the Fibrovic Study - ANRS HC02
Authors : P.Cacoub, [...], G. Pénaranda, [...], P.Halfon
57th Annual Meeting of the American Association for the Studyof Liver Diseases (AASLD), Boston (October 2006)
| Meta-analysis of blood scores for liver fibrosis in chronic hepatitis C
Authors : P.Calès, [...], G. Pénaranda, [...], C.Trocme
57th Annual Meeting of the American Association for the Studyof Liver Diseases (AASLD), Boston (October 2006)
| Chronic Chlamydia pneumoniae infection in patients with symptomatic atherothrombosis
Authors : P. Halfon, N. Limal, G. Pénaranda, [...], P. Cacoub
Published in : Journal of Infection (August 2006)
| Real time PCR Assays for Hepatitis C Virus (HCV) RNA Quantification Are Adequate for Clinical Management of Patients with Chronic HCV Infection
Authors : P. Halfon, [...], G. Pénaranda, [...], D.Ouzan
Published in : Journal of Clinical Microbiology (July 2006)
| Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C : can you avoid liver biopsy?
Authors : Y.Maor, [...], G. Pénaranda, [...], P. Halfon
Published in : Haemophilia (July 2006)
| Combination of Non Invasive Markers (Fibrotest, Hepascore, APRI, and Forns) to Identify Liver Fibrosis in HCV-Infected Patients and to Avoid Liver Biopsy
Authors : M. Bourlière, [...], G. Pénaranda, [...], P.Halfon
12th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD), Paris (July 2006)
| Multicentre study of hepatitis B virus genotypes in France : correlation with liver fibrosis and hepatitis B e antigen status
Authors : P. Halfon, [...], G. Pénaranda, [...], P.Cacoub
Published in : Journal of Viral Hepatitis (May 2006)
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome : complete biochemical and histological response to therapy with ursodesoxycholic acid
Authors : C.Renou, [...], G. Pénaranda, [...],P.Halfon
Published in : Journal of Gastroenterology and Hepatology (April 2006)
| Independent prospective multicenter validation of biochemical markers (Fibrotest - Actitest) for the prediction of liver fibrosis and activity in patients with chronis hepatitis C : The FIBROPACA study
Authors : P. Halfon, [...], R. Deydier, [...], G. Pénaranda, [...], D. Ouzan
Published in : American Journal of Gastroenterology (March 2006)
| Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard : implications for clinical management of patients with chronic hepatitis C virus infection
Authors : P. Halfon, G. Pénaranda, [...], D. Ouzan
Published in : Journal of Medical Virology (February 2006)
| Medically assisted procreation and transmission of hepatitis C virus : absence of HCV RNA in purified sperm fraction in HIV co-infected patients
Authors : P. Halfon, [...], G. Pénaranda, [...], R. Roulier
Published in : AIDS (January 2006)
| |
| Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patients
Authors : D. Ouzan, H. Khiri, G. Pénaranda, [...], P. Halfon
Published in : Comparative Hepatology (Dec 2005)
| |
|
|
|
